BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31872386)

  • 1. Impact of BRCA1 and BRCA2 mutations on ovarian reserve and fertility preservation outcomes in young women with breast cancer.
    Porcu E; Cillo GM; Cipriani L; Sacilotto F; Notarangelo L; Damiano G; Dirodi M; Roncarati I
    J Assist Reprod Genet; 2020 Mar; 37(3):709-715. PubMed ID: 31872386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Walking the tightrope: Fertility preservation among hereditary breast and ovarian Cancer syndrome Previvors.
    Holtzman S; McCarthy L; Estevez SL; Lee JA; Baird MF; Gounko D; Copperman AB; Blank SV
    Gynecol Oncol; 2024 Apr; 186():176-181. PubMed ID: 38696905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decision regret and associated factors following oocyte cryopreservation in patients with diminished ovarian reserve and/or age-related fertility decline.
    Gurbuz A; Cil AP; Karakis LS; Abali R; Ceyhan M; Aksakal E; Kilic A; Bahceci M; Urman B
    J Assist Reprod Genet; 2021 Jun; 38(6):1469-1479. PubMed ID: 33797008
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Tanaka H; Motooka Y; Maeda Y; Sonehara R; Nakamura T; Kajiyama H; Mashimo T; Toyokuni S
    Free Radic Res; 2024 Feb; 58(2):130-143. PubMed ID: 38394084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian reserve of women with and without BRCA pathogenic variants: A systematic review and meta-analysis.
    Gasparri ML; Di Micco R; Zuber V; Taghavi K; Bianchini G; Bellaminutti S; Meani F; Graffeo R; Candiani M; Mueller MD; Papadia A; Gentilini OD
    Breast; 2021 Dec; 60():155-162. PubMed ID: 34627117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fertility preservation in breast cancer with case-based examples for guidance.
    Hampe ME; Rhoton-Vlasak AS
    J Assist Reprod Genet; 2020 Mar; 37(3):717-729. PubMed ID: 32008180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fertility Preservation: Current and Future Perspectives for Oncologic Patients at Risk for Iatrogenic Premature Ovarian Insufficiency.
    Pinelli S; Basile S
    Biomed Res Int; 2018; 2018():6465903. PubMed ID: 30112413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do Fertility Preservation Outcomes in Patients Diagnosed with Lymphoma Differ Based on Cancer Stage?
    Kocsuta V; Shah S; Lawson AK; Pavone ME
    J Adolesc Young Adult Oncol; 2024 Apr; 13(2):300-306. PubMed ID: 36809174
    [No Abstract]   [Full Text] [Related]  

  • 9. Ovarian reserve in patients with FMR1 gene premutation and the role of fertility preservation.
    Poulennec TL; Dubreuil S; Grynberg M; Chabbert-Buffet N; Sermondade N; Fourati S; Siffroi JP; Héron D; Bachelot A
    Ann Endocrinol (Paris); 2024 May; ():. PubMed ID: 38702011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospectively assessing risk for premature ovarian senescence in young females: a new paradigm.
    Gleicher N; Kushnir VA; Barad DH
    Reprod Biol Endocrinol; 2015 Apr; 13():34. PubMed ID: 25906823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responses to fertility treatment among patients with cancer: a retrospective cohort study.
    Dolinko AV; Farland LV; Missmer SA; Srouji SS; Racowsky C; Ginsburg ES
    Fertil Res Pract; 2018; 4():3. PubMed ID: 29692923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Machine learning for predicting elective fertility preservation outcomes.
    Braude I; Haikin Herzberger E; Semo M; Soifer K; Goren Gepstein N; Wiser A; Miller N
    Sci Rep; 2024 May; 14(1):10158. PubMed ID: 38698132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Systemic Therapy on Fertility in Women with Early-Stage Breast Cancer.
    Natsuhara KH; Chien AJ
    Curr Breast Cancer Rep; 2024 Mar; 16(1):61-68. PubMed ID: 38645685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing the Perspective on Fertility Preservation for Women with Metastatic or Advanced Stage Cancer.
    Abel MK; Wang A; Letourneau JM; Melisko ME; Cedars MI; Rosen MP
    Curr Oncol Rep; 2024 Apr; ():. PubMed ID: 38639793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer in young women.
    Gabriel CA; Domchek SM
    Breast Cancer Res; 2010; 12(5):212. PubMed ID: 21067532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA1/2 genes mutations, ovarian reserve and female reproductive outcomes: a systematic review of the literature.
    Merlino L; Chiné A; Galli C; Piccioni MG
    Minerva Ginecol; 2020 Oct; 72(5):339-348. PubMed ID: 32744451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fertility preservation in BRCA mutation carriers-efficacy and safety issues: a review.
    Zhang X; Niu J; Che T; Zhu Y; Zhang H; Qu J
    Reprod Biol Endocrinol; 2020 Feb; 18(1):11. PubMed ID: 32070378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fertility preservation in patients with
    Ghunaim S; Ghazeeri G; Khalife D; Azim HA
    Ecancermedicalscience; 2020; 14():1033. PubMed ID: 32419845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COH outcomes in breast cancer patients for fertility preservation: a comparison with the expected response by age.
    Malacarne E; Devesa M; Martinez F; Rodriguez I; Coroleu B
    J Assist Reprod Genet; 2020 Dec; 37(12):3069-3076. PubMed ID: 32945994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preserving fertility in young women undergoing chemotherapy for early breast cancer; the Maastricht experience.
    Vriens IJH; Ter Welle-Butalid EM; de Boer M; de Die-Smulders CEM; Derhaag JG; Geurts SME; van Hellemond IEG; Luiten EJT; Dercksen MW; Lemaire BMD; van Haaren ERM; Vriens BEPJ; van de Wouw AJ; van Riel AMGH; Janssen-Engelen SLE; van de Poel MHW; Schepers-van der Sterren EEM; van Golde RJT; Tjan-Heijnen VCG
    Breast Cancer Res Treat; 2020 May; 181(1):77-86. PubMed ID: 32236826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.